Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers

Sandra Russo, Joan L. Walker, Jay W. Carlson, Jeanne Carter, Leigh C. Ward, Allan Covens, Edward J. Tanner, Jane M. Armer, Sheila Ridner, Sandi Hayes, Alphonse G. Taghian, Cheryl Brunelle, Micael Lopez-Acevedo, Brittany A. Davidson, Mark V. Schaverien, Sharad A. Ghamande, Michael Bernas, Andrea L. Cheville, Kathleen J. Yost, Kathryn SchmitzBarbara Coyle, Jeannette Zucker, Danielle Enserro, Stephanie Pugh, Electra D. Paskett, Leslie Ford, Worta McCaskill-Stevens

Research output: Contribution to journalReview articlepeer-review

Abstract

Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.

Original languageEnglish (US)
Pages (from-to)625-632
Number of pages8
JournalGynecologic Oncology
Volume160
Issue number2
DOIs
StatePublished - Feb 2021

Keywords

  • Gynecologic cancers
  • Lymphedema
  • Oncologic surgical treatment
  • Patient reported outcomes
  • Quantitative measurements

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers'. Together they form a unique fingerprint.

Cite this